Cargando…
Mutations in epigenetic regulators including SETD2 are gained during relapse in pediatric acute lymphoblastic leukemia
Relapsed pediatric acute lymphoblastic leukemia (ALL) has high rates of treatment failure. Epigenetic regulators have been proposed as modulators of chemoresistance, here we sequence genes encoding epigenetic regulators in matched diagnosis-remission-relapse ALL samples. We find significant enrichme...
Autores principales: | Mar, Brenton G, Bullinger, Lars B, McLean, Kathleen M, Grauman, Peter V, Harris, Marian H, Stevenson, Kristen, Neuberg, Donna S, Sinha, Amit U, Sallan, Stephen E, Silverman, Lewis B, Kung, Andrew L, Nigro, Luca Lo, Ebert, Benjamin L, Armstrong, Scott A |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4016990/ https://www.ncbi.nlm.nih.gov/pubmed/24662245 http://dx.doi.org/10.1038/ncomms4469 |
Ejemplares similares
-
Hedgehog pathway mutations drive oncogenic transformation in high-risk T-cell acute lymphoblastic leukemia
por: Burns, Melissa A., et al.
Publicado: (2018) -
Repression of BIM mediates survival signaling by MYC and AKT in high-risk T-cell acute lymphoblastic leukemia
por: Reynolds, Christine, et al.
Publicado: (2014) -
Long-term results of Dana-Farber Cancer Institute ALL Consortium protocols for children with newly diagnosed acute lymphoblastic leukemia (1985–2000)
por: Silverman, Lewis B., et al.
Publicado: (2009) -
Long-term outcome of a pediatric-inspired regimen used for adults aged 18–50 years with newly diagnosed acute lymphoblastic leukemia
por: DeAngelo, D J, et al.
Publicado: (2015) -
PRC2 loss induces chemoresistance by repressing apoptosis in T cell acute lymphoblastic leukemia
por: Ariës, Ingrid M., et al.
Publicado: (2018)